www.oyez.org/cases/2016/15-1039

Apr 26, 2017 ... Sandoz Inc. v. ... Amgen Inc., et al. ... In May 2014, Sandoz Inc. filed an application for FDA approval of its product Zarxio, which was highly ...

www.scotusblog.com/case-files/cases/amgen-inc-v-harris-2

Nov 13 2015, Brief of respondents Steve Harris, et al. in opposition filed. Dec 1 2015, Reply of petitioners Amgen Inc., et al. filed. Dec 2 2015, DISTRIBUTED for  ...

www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-1480.Opinion.10-2-2017.1.PDF

Oct 5, 2017 ... LIMITED, AMGEN USA, INC.,. Plaintiffs-Appellees v. SANOFI, AVENTISUB LLC .... All references are to the '165 patent unless other-.

www.supremecourt.gov/opinions/16pdf/15-1039_1b8e.pdf

Jun 12, 2017 ... Syllabus. SANDOZ INC. v. AMGEN INC. ET AL. CERTIORARI TO THE ... Administration (FDA) approval of a drug that is biosimilar to an al-.

www.patentdocs.org/2017/06/sandoz-inc-v-amgen-inc-2017.html

Jun 12, 2017 ... Amgen Inc., marking the first time the Court has interpreted the Biologics Price ... Earlier today, the Supreme Court handed down its opinion in Sandoz Inc. v. .... that delays all biosimilars by 180 days after approval is improper.

phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDIwNjg2fENoaWxkSUQ9NDM0MjI1fFR5cGU9MQ==&t=1

Apr 6, 2011 ... Cummings SR et al. N Engl J Med. .... bowling, play tennis and football, and do many things I .... Ilypsa in 2007, Abgenix and Avidia in 2006, and Tularik Inc. in 2004. ...... Immunex Corporation; Constance Thompson, et al., v.